CUNDY KENNETH C.,MANTHATI SURESH K,WUSTROW DAVID J.
申请号：
NZ62972813
公开号：
NZ629728A
申请日:
2013.02.07
申请国别(地区):
NZ
年份:
2016
代理人:
摘要：
Morpholinoalkyl fumarates, pharmaceutical compositions comprising the morpholinoalkyl fumarates, and methods of using morpholinoalkyl fumarates and pharmaceutical compositions for treating neurodegenerative, inflammatory, and autoimmune disorders including multiple sclerosis, psoriasis, irritable bowel disorder, ulcerative colitis, arthritis, chronic obstructive pulmonary disease, asthma, Parkinson&rsquos disease, Huntington&rsquos disease, and amyotrophic lateral sclerosis are disclosed. An example of the compound is methyl (S-morpholinopentyl) fumarate HCl salt.
